Detalles de la búsqueda
1.
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.
JTO Clin Res Rep
; 4(10): 100562, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37744308
Resultados
1 -
1
de 1
1
Próxima >
>>